Susquehanna International Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6969 |
|
|
2024
Q4 | – | Sell |
-32,553
| Closed | -$25.3K | – | 6694 |
|
|
2024
Q3 | $25.3K | Sell |
32,553
-66,050
| -67% | -$51.3K | ﹤0.01% | 5380 |
|
|
2024
Q2 | $74K | Buy |
98,603
+1,821
| +2% | +$1.37K | ﹤0.01% | 5184 |
|
|
2024
Q1 | $103K | Sell |
96,782
-3,296
| -3% | -$3.49K | ﹤0.01% | 4998 |
|
|
2023
Q4 | $105K | Sell |
100,078
-3,904
| -4% | -$4.1K | ﹤0.01% | 5327 |
|
|
2023
Q3 | $116K | Sell |
103,982
-8,790
| -8% | -$9.85K | ﹤0.01% | 4856 |
|
|
2023
Q2 | $170K | Sell |
112,772
-12,754
| -10% | -$19.2K | ﹤0.01% | 4736 |
|
|
2023
Q1 | $196K | Buy |
125,526
+21,436
| +21% | +$33.4K | ﹤0.01% | 4885 |
|
|
2022
Q4 | $66.3K | Sell |
104,090
-75,424
| -42% | -$48.1K | ﹤0.01% | 5092 |
|
|
2022
Q3 | $239K | Buy |
179,514
+28,645
| +19% | +$38.1K | ﹤0.01% | 4540 |
|
|
2022
Q2 | $335K | Buy |
150,869
+20,161
| +15% | +$44.8K | ﹤0.01% | 3849 |
|
|
2022
Q1 | $809K | Sell |
130,708
-354,350
| -73% | -$2.19M | ﹤0.01% | 3092 |
|
|
2021
Q4 | $6.12M | Buy |
485,058
+426,027
| +722% | +$5.38M | ﹤0.01% | 1058 |
|
|
2021
Q3 | $5.41M | Buy |
59,031
+10,893
| +23% | +$998K | ﹤0.01% | 1112 |
|
|
2021
Q2 | $2.55M | Sell |
48,138
-32,062
| -40% | -$1.7M | ﹤0.01% | 1832 |
|
|
2021
Q1 | $2.89M | Buy |
+80,200
| New | +$2.89M | ﹤0.01% | 1725 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5207 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4868 |
|